outcomes
Outcomes in CE have traditionally relied on pre- and post-education assessment of knowledge, competence and/or performance.
By: Katie Robinson, Ph.D., CHCP
outcomes
In this article, we summarize results of the first-ever survey of Alliance members’ usage of, attitudes toward and concerns about the use of generative AI in CME/CPD.
By: Andrew D. Bowser, ELS, CHCP; Brian McGowan, Ph.D., FACEHP; Andrew Crim M.Ed., CHCP, FACEHP; and Dustin Ensign, BSc, CHCP
outcomes
“To attend those who suffer, a physician must possess not only the scientific knowledge and technical abilities, but also an understanding of human nature. The patient is not just a group of symptoms, damaged organs and altered emotions....
By: Milini Mingo, MPA, CHCP
outcomes
In the dynamic healthcare landscape, the success of innovative practices and technologies often hinges on the readiness of clinicians to embrace transformative change.
By: Dustin Ensign, BSc, CHCP
outcomes
ECHO HBV Global was submitted for consideration of the Outstanding Educational Collaboration Award because it was not only designed to address this important global health issue through education in regions with high prevalence of hepatitis B by...
outcomes
This series and its authors received the Almanac Author of the Year Award at the Alliance 2024 Annual Conference. Read the full series: Part 1, Part 2, Part 3 and Part 4.
By: Wendy Cerenzia, MS; Sarah Nisly, PharmD, MEd, BCPS, FCCP; Caroline Pardo, Ph.D., CHCP, FACEHP; and Emily Belcher
outcomes
Over the past decade, our CE/CPD community has made significant progress in the science and delivery of outcomes. This work has contributed to the impact of various disease-state medical affairs goals across industry.
By: Greselda Butler, CHCP, FACEHP; Sue L. McGuinness, Ph.D., CHCP; John Ruggiero, Ph.D., MPA, BCS; and LB Wong, RN, MSN, MBA
outcomes
In part four of our ongoing series “Advancing Continuing Medical Education: Reflecting on the Past and Charting a Path Forward,” we shift focus to outcomes measurement as an integrated part of the educational design, identifying the...
By: Emily Belcher and Wendy Cerenzia, MS
outcomes
In 2019, an emerging therapy showing promising results in breast cancers with low levels of HER2 began to emerge, indicating significant changes would need to be made in the testing, reporting and tracking of a patient’s HER2 status.
By: Melissa Kelly, PhD; Joseph Kim, MD, MPH, MBA; and Kellie Beumer, MBA